SeaStar Medical (ICU)
1.88
-0.03 (-1.57%)
At close: Jan 15, 2025, 12:27 PM
undefined% (undefined)
| Bid | 1.87 |
| Market Cap | 8.39M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -10.19 |
| PE Ratio (ttm) | -0.18 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 1.88 |
| Volume | 70,711 |
| Avg. Volume (20D) | 235,462 |
| Open | 1.96 |
| Previous Close | 1.91 |
| Day's Range | 1.84 - 1.96 |
| 52-Week Range | 1.70 - 42.92 |
| Beta | undefined |
About ICU
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune ...
Industry Biotechnology
Sector Healthcare
IPO Date Mar 18, 2021
Employees 12
Stock Exchange NASDAQ
Ticker Symbol ICU
Website https://www.seastarmedical.com
Analyst Forecast
According to 1 analyst ratings, the average rating for ICU stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
2 months ago ·
Source
+11.73%
SeaStar Medical shares are trading higher after th...
Unlock content with
Pro Subscription
2 months ago ·
Source
-22.22%
SeeStar Medical shares are trading lower after the company reported worse-than-expected Q3 revenue results.
